[HTML][HTML] Impact of aging on treatment considerations for multiple sclerosis patients
G Macaron, C Larochelle, N Arbour, M Galmard… - Frontiers in …, 2023 - frontiersin.org
With a rapidly aging global population and improvement of outcomes with newer multiple
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
Impact of aging on treatment considerations for multiple sclerosis patients
G Macaron, C Larochelle, N Arbour… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
With a rapidly aging global population and improvement of outcomes with newer multiple
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
Impact of aging on treatment considerations for multiple sclerosis patients.
G Macaron, C Larochelle, N Arbour… - Frontiers in …, 2023 - europepmc.org
With a rapidly aging global population and improvement of outcomes with newer multiple
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
[HTML][HTML] Impact of aging on treatment considerations for multiple sclerosis patients
G Macaron, C Larochelle, N Arbour… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
With a rapidly aging global population and improvement of outcomes with newer multiple
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …
sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has …